Apimeds Pharmaceuticals US, Inc (APUS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 20.04K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -20.04K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 4.05M | 7.04M | 1.84M | 2.66M | 364.37K | 275.61K | 300K | 427.76K | 271.73K | 559.07K | 104.16K | 66.19K |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 11.28M | 6.68M | 1.22M | 2.01M | 364.37K | 275.61K | 300K | 427.76K | 271.73K | 530.52K | 107.16K | 4.07K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 901.14K | 361.1K | 619.69K | 651.78K | 0 | 0 | 0 | 0 | 0 | 28.55K | -3K | 62.12K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.07M | -7.04M | -1.84M | -2.66M | -364.37K | -275.61K | -300K | -427.76K | -271.73K | -559.07K | -104.16K | -66.19K |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -1017.65% | -2454.32% | -514.75% | -522.76% | -34.09% | 50.7% | -188.03% | - | - | -744.7% | - | - |
| EBITDA | -4.05M | -7.04M | -1.84M | -2.66M | -364.37K | -275.58K | -299.88K | -427.24K | -269.56K | -553.49K | -101.93K | -66.19K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -1012.16% | -2453.16% | -514.49% | -523.46% | -35.17% | 50.21% | -194.21% | - | - | -736.26% | - | - |
| D&A (Non-Cash Add-back) | 20.04K | 3.98K | 1.49K | 232 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -34.2M | -939.67K | -1.77M | -2.64M | -364.37K | -275.58K | -299.88K | -427.24K | -269.56K | -553.49K | -101.93K | -66.19K |
| Net Interest Income | -859.4K | -179.71K | 50.13K | -7.81K | -38.03K | -36.02K | -32.52K | -21.61K | -24.75K | -7.89K | -5.86K | -8.41K |
| Interest Income | 7 | 35.92K | 56.43K | 15.25K | 3 | 30 | 116 | 517 | 2.16K | 5.58K | 2.23K | 0 |
| Interest Expense | 859.4K | 215.62K | 6.3K | 23.05K | 38.03K | 36.05K | 32.64K | 22.12K | 26.91K | 13.48K | 8.09K | 8.41K |
| Other Income/Expense | -30.99M | 5.88M | 62.98K | 1.71K | -38.03K | -36.02K | -32.52K | -21.61K | -24.75K | -7.89K | -5.86K | -8.41K |
| Pretax Income | -35.06M | -1.16M | -1.78M | -2.66M | -402.4K | -311.63K | -332.52K | -449.36K | -296.47K | -566.97K | -110.02K | -74.59K |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -35.06M | -1.16M | -1.78M | -2.66M | -402.4K | -311.63K | -332.52K | -449.36K | -296.47K | -566.97K | -110.02K | -74.59K |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -8612.75% | -270.72% | -435.68% | -492.44% | -35.73% | 45.03% | -202.24% | - | - | -660.07% | - | - |
| Net Income (Continuing) | -35.06M | -1.16M | -1.78M | -2.66M | -402.4K | -311.63K | -332.52K | -449.36K | -296.47K | -566.97K | -110.02K | -74.59K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -2.26 | -0.09 | -1.40 | -2.60 | -0.35 | -0.25 | -0.26 | -0.35 | -0.23 | -0.45 | -0.09 | -0.06 |
| EPS Growth % | -549.43% | 62.64% | -434.35% | -634.46% | -48.72% | 44.97% | -201.15% | - | - | -657.63% | - | - |
| EPS (Basic) | -2.26 | -0.09 | -1.40 | -2.60 | -0.35 | -0.27 | -0.29 | -0.39 | -0.26 | -0.49 | -0.10 | -0.07 |
| Diluted Shares Outstanding | 15.51M | 10.88M | 1.26M | 1.04M | 1.16M | 1.27M | 1.27M | 1.27M | 1.27M | 1.27M | 1.27M | 1.27M |
| Basic Shares Outstanding | 15.51M | 10.88M | 1.26M | 1.04M | 1.16M | 1.15M | 1.15M | 1.15M | 1.15M | 1.15M | 1.15M | 1.15M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |